{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-24-000002","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.152366+00:00","generated_at":"2026-06-07T02:09:25.589078+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OrthoPediatrics prelim Q4 revenue $37.6M (+21%); acquires Boston O&P; 2024 guidance $197-200M","bullets":["Preliminary Q4 2023 net revenue $37.6M (up 21% YoY); full year $148.7M (up 22%).","Domestic Q4 rev $28.3M (+24%), int'l $9.3M (+13%). FY domestic $111.0M (+20%), int'l $37.7M (+26%).","Acquired Boston O&P on Jan 5, 2024 (annual revenue ~$25M); deal expected accretive to adjusted EBITDA in 2024.","2024 revenue guidance $197M-$200M (32-34% growth). Cash ~$60M post-acquisition; new $30M term + $50M revolver.","Acquisition of Boston O&P was also a customer/supplier; Q4 helped ~20k kids, cumulative >710k."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-24-000002","json":"https://secwatch.observer/filing/0001425450-24-000002.json","markdown":"https://secwatch.observer/filing/0001425450-24-000002.md","text":"https://secwatch.observer/filing/0001425450-24-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000002/0001425450-24-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000002/kids-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:09:25.589078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c5fab884269b8ee4ec062a2a16fdc000a16836d4","claim":"ORTHOPEDIATRICS CORP reported the fourth quarter ended December 31, 2023 results: revenue $37.6 million.","evidence_excerpt":"Preliminary unaudited fourth quarter 2023 net revenue is expected to be $37.6 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000002/0001425450-24-000002-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$37.6 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"d96a81529b9001c917ede56df13fb953df77f322","claim":"ORTHOPEDIATRICS CORP reported the full year ended December 31, 2023 results: revenue $148.7 million.","evidence_excerpt":"Preliminary unaudited full year 2023 net revenue is expected to be $148.7 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000002/0001425450-24-000002-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Revenue","value":"$148.7 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"e7093a1803faeddcad7caee013510b55f8b8a6a6","claim":"ORTHOPEDIATRICS CORP reported the fiscal year ending December 31, 2024 results: revenue $197 million to $200 million. Guidance initiated.","evidence_excerpt":"OrthoPediatrics projects 2024 revenue to be in the range of $197 million to $200 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000002/0001425450-24-000002-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ending December 31, 2024"},{"label":"Revenue","value":"$197 million to $200 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}